Article Text
Abstract
Blood banks all over the world attempt to cover the demand for blood by donations from voluntary non-remunerated donors. The discussion regarding the acceptability of blood donations by haemochromatosis patients focuses on the question of whether health benefits violate the rule of the altruistic donor. Utilitarian and deontological arguments for and against the policy of accepting blood donors who need to let blood regularly in order to stay healthy are considered by this article. A closer look at the procedure reveals that the confusion is due to the conflation of, on the one hand the phlebotomy, and on the other hand, the decision about the destination of the blood afterwards. The health benefits are connected to the phlebotomy and not to the donation. The morally relevant point in the decision as to whether the candidate is a truly altruistic donor is whether he donates without asking for a benefit in return. It is concluded that haemochromatosis patients can be free, voluntary, and altruistic blood donors.
- altruism
- blood
- donation
- haemochromatosis
- motivation
Statistics from Altmetric.com
Footnotes
-
Research for this article was made possible by grant G.0065.00 from the Fund for Scientific Research—Flanders, Belgium.
Read the full text or download the PDF:
Other content recommended for you
- Duodenal expression of iron transport molecules in untreated haemochromatosis subjects
- The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading
- Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients
- Diagnosis and management of hereditary haemochromatosis
- PTH-130 Facilitation of Blood Donation amongst Haemochromatosis Patients: a UK Pilot
- Knowledge level and motivation of Hong Kong young adults towards blood donation: a cross-sectional survey
- Disorders of iron metabolism. Part II: iron deficiency and iron overload
- More blood for India
- Laboratory costs of a hospital-based blood transfusion service in Malawi
- HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis